Literature DB >> 8645777

Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.

L C Kopala1, D Fredrikson, K P Good, W G Honer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645777     DOI: 10.1016/0006-3223(95)00500-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  7 in total

Review 1.  The Canadian experience with risperidone for the treatment of schizophrenia: an overview.

Authors:  M Iskedjian; M Hux; G J Remington
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

Review 2.  Neurocognition: clinical and functional outcomes in schizophrenia.

Authors:  Martin Lepage; Michael Bodnar; Christopher R Bowie
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

3.  Clinical features of schizophrenia in a woman with hyperandrogenism.

Authors:  L C Kopala; R Lewine; K P Good; M Fluker; J S Martzke; J S Lapointe; W G Honer
Journal:  J Psychiatry Neurosci       Date:  1997-01       Impact factor: 6.186

4.  Trait vs. State Markers for Schizophrenia: Identification and Characterization through Visual Processes.

Authors:  Yue Chen; L Cinnamon Bidwell; Daniel Norton
Journal:  Curr Psychiatry Rev       Date:  2006-11

Review 5.  Pharmacological management of first-episode schizophrenia and related nonaffective psychoses.

Authors:  Daniel W Bradford; Diana O Perkins; Jeffrey A Lieberman
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Efficacy and Tolerability of Paliperidone Extended-release in the Treatment of First-episode Psychosis: An Eight-week, Open-label, Multicenter Trial.

Authors:  Nam-In Kang; Bon-Hoon Koo; Sung-Wan Kim; Jong-Hoon Kim; Beomwoo Nam; Bong-Ju Lee; Sang-Hyuk Lee; Seung Jae Lee; Seung-Hwan Lee; Myung Hun Jung; Sang Woo Hahn; Young-Chul Chung
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-08-31       Impact factor: 2.582

Review 7.  The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis.

Authors:  Michael Davidson; Asaf Caspi; Shlomo Noy
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.